Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N = 4532)

Monica Montopoli(University of Padua), Sara Zumerle(University of Padua), Roberto Vettor(University of Padua), Massimo Rugge(University of Padua), Manuel Zorzi(Fondazione Progetto Ematologia), Carlo V. Catapano(Institute of Oncology Research), Giuseppina M. Carbone(Institute of Oncology Research), Andrea Cavalli(Università della Svizzera italiana), Francesco Pagano(Veneto Institute of Molecular Medicine), Eugenio Ragazzi(University of Padua), T. Prayer-Galetti(Azienda Ospedale - Università Padova), Andrea Alimonti(University of Padua)
Annals of Oncology
May 6, 2020
Cited by 545Open Access
Full Text

Abstract


Related Papers